1. Home
  2. BV vs ANL Comparison

BV vs ANL Comparison

Compare BV & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightView Holdings Inc.

BV

BrightView Holdings Inc.

HOLD

Current Price

$9.92

Market Cap

1.0B

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$15.91

Market Cap

998.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BV
ANL
Founded
1939
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
998.8M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
BV
ANL
Price
$9.92
$15.91
Analyst Decision
Hold
Strong Buy
Analyst Count
5
1
Target Price
$14.50
★ $20.00
AVG Volume (30 Days)
★ 771.6K
156.8K
Earning Date
05-05-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$4.61
$36.02
Revenue Next Year
$1.90
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.11
$0.88
52 Week High
$15.00
$17.25

Technical Indicators

Market Signals
Indicator
BV
ANL
Relative Strength Index (RSI) 27.35 55.87
Support Level N/A $12.45
Resistance Level $11.99 $17.25
Average True Range (ATR) 0.28 1.06
MACD -0.04 0.00
Stochastic Oscillator 0.00 44.67

Price Performance

Historical Comparison
BV
ANL

About BV BrightView Holdings Inc.

BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage company at the forefront of discovering and developing cancer therapies. The company is building a robust pipeline of drug candidates focused on two key areas where it believes it can make a difference RAS-targeting therapies: its is tackling RAS-driven cancers with AN9025, an oral pan-RAS(ON) inhibitor, and AN4035, a CEACAM5-targeting ADC delivering a potent pan-RAS(ON) inhibitor directly to tumors; Next-generation cancer immunotherapies: its candidates, AN8025 (a tri-functional fusion protein of alphaPD-L1 x CD86 variant x LAG3 variant), a T-cell and antigen-presenting cell modulator, and AN4005 (a first-in-class oral small-molecule PD-L1 inhibitor), are designed to activate cancer immunity in novel ways.

Share on Social Networks: